These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3131033)

  • 21. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in tumor pO2 by perfluorochemicals and carbogen.
    Hasegawa T; Rhee JG; Levitt SH; Song CW
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):569-74. PubMed ID: 3104250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA; Holden SA; Ara G; Ha CS; Herman TS; Northey D
    J Cancer Res Clin Oncol; 1992; 118(7):509-14. PubMed ID: 1624542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased radiosensitivity of tumors by perfluorochemicals and carbogen.
    Song CW; Zhang WL; Pence DM; Lee I; Levitt SH
    Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1833-6. PubMed ID: 3930442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA; Herman TS; Rose CM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin.
    Teicher BA; Lazo JS; Merrill WW; Filderman AE; Rose CM
    Cancer Chemother Pharmacol; 1986; 18(3):213-8. PubMed ID: 2433068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S; Mate TP; Irvin CG; Nierenburg M
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
    Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
    Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in RBC flux, acidosis and oxygenation in tumour microregions by Fluosol-DA 20%.
    Lee I; Cunningham WP; Levitt SH
    Int J Radiat Biol; 1991 Oct; 60(4):695-705. PubMed ID: 1680148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
    Teicher BA; Rose CM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1311-3. PubMed ID: 3093415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of Fluosol-DA on the occurrence of lung metastases in Lewis lung carcinoma and B16 melanoma.
    Teicher BA; Jacobs JL; Kelley MJ
    Invasion Metastasis; 1988; 8(1):45-56. PubMed ID: 3343092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of rat brain tumor therapy by fluosol and carbogen.
    Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS
    NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
    Holden SA; Teicher BA; Ha C; Ara G; Herman TS
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):895-8. PubMed ID: 1391529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
    Rockwell S; Irvin CG; Kelley M
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):913-20. PubMed ID: 3141320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in radiation sensitization induced by Fluosol-DA as measured by 31P nuclear magnetic resonance spectroscopy.
    Koutcher JA; Alfieri AA; Kornblith AB; Devitt ML; Cowburn D; Ballon D; Kim JH
    Cancer Res; 1990 Nov; 50(22):7252-6. PubMed ID: 2121332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in tumor response to fluosol-DA (20%).
    Sasai K; Ono K; Nishidai T; Tsutsui K; Shibamoto Y; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1149-52. PubMed ID: 2497093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
    Teicher BA; Herman TS; Hopkins RE; Menon K
    J Cancer Res Clin Oncol; 1992; 118(2):123-8. PubMed ID: 1735732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
    Moulder JE; Fish BL
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.